Talking Points

Autor: Vários
Narrador: Vários
Editor: Podcast
Duración: 27:21:42

Mas informaciones

Seguir

Escucha

Sinopsis

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.

Episodios

Episode 119: The STRENGTH Trial

02/06/2021 Duración: 11min

A. Michael Lincoff and C. Michael Gibson discuss CV outcomes with omega-3 carboxylic acids in patients with high vascular risk and atherogenic dyslipidemia.

Escucha
Episode 118: The OPTIMIZE Trial

19/05/2021 Duración: 10min

Dean Kereiakes and C. MIchael Gibson discuss a randomized trial of a novel, ultra-low-profile fixed-wire DES.

Escucha
Episode 117: The AHA COVID-19 CVD Registry

06/05/2021 Duración: 15min

Robert Harrington and C. Michael Gibson discuss the registry's design, implementation, and initial results.

Escucha
Episode 116: The TANGO Trial

21/04/2021 Duración: 06min

Ehrin Armstrong and C. Michael Gibson discuss a randomized, dose-escalation trial of temsirolimus adventitial delivery below the knee.

Escucha
Episode 115: The GALACTIC-HF Trial

07/04/2021 Duración: 14min

John Teerlink and C. Michael Gibson discuss omecamtiv mecarbil in chronic HFrEF.

Escucha
Episode 114: The NACMI COVID-19 Registry

24/03/2021 Duración: 28min

Timothy Henry and C. Michael Gibson discuss outcomes from the North American registry.

Escucha
Episode 113: The EXPLORER-HCM Trial

17/03/2021 Duración: 10min

Iacopo Olivotto and C. Michael Gibson discuss mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.

Escucha
Episode 112: FLASH Registry: Acute Hemodynamic Improvement

03/03/2021 Duración: 06min

C. Michael Gibson and Catalin Toma discuss acute hemodynamic improvement with percutaneous mechanical thrombectomy in a real-world pulmonary embolism population.

Escucha
Episode 111: The PARALLAX Trial

17/02/2021 Duración: 09min

Burkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.

Escucha
Episode 110: The HOME-PE Trial

03/02/2021 Duración: 09min

Pierre-Marie Roy and C. Michael Gibson discuss hospitalization or outpatient management of PE.

Escucha
Episode 109: The EAST-AFNET 4 Trial

20/01/2021 Duración: 14min

Paulus Kirchhof and C. Michael Gibson discuss early rhythm control therapy in patients with atrial fibrillation.

Escucha
Episode 108: The BPLTTC Trial

06/01/2021 Duración: 05min

Kazem Rahimi and C. Michael Gibson discuss BP-lowering for prevention of cardiovascular events.

Escucha
Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease

16/12/2020 Duración: 07min

Dr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease.

Escucha
Episode 106: TCT Connect 2020

02/12/2020 Duración: 28min

C. Michael Gibson, Ajay Kirtane, Mamas Mamas, and Roxana Mehran talk TCT 2020.

Escucha
Episode 105: POPULAR TAVI

04/11/2020 Duración: 06min

C. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.

Escucha
Episode 104: EMPEROR Reduced

21/10/2020 Duración: 16min

C. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.

Escucha
Episode 103: New ESC NSTEMI Guidelines

07/10/2020 Duración: 09min

C. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more

Escucha
Episode 102: Innovation in Mitral Valve Repair

02/09/2020 Duración: 02min

C. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.

Escucha
Episode 101: PARTNER 2A: 5-Year Outcomes

19/08/2020 Duración: 02min

C. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.

Escucha
Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3

05/08/2020 Duración: 05min

Suzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.

Escucha